Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$0.51 - $7.56 $1,479 - $21,924
2,900 Added 21.08%
16,655 $8,000
Q2 2022

Aug 11, 2022

BUY
$0.43 - $1.24 $5,914 - $17,056
13,755 New
13,755 $8,000
Q4 2021

Feb 11, 2022

SELL
$1.69 - $2.46 $21,878 - $31,847
-12,946 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$2.38 - $3.77 $30,811 - $48,806
12,946 New
12,946 $31,000
Q2 2021

Aug 10, 2021

SELL
$3.49 - $5.51 $86,538 - $136,625
-24,796 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$5.37 - $10.72 $27,365 - $54,629
5,096 Added 25.87%
24,796 $137,000
Q4 2020

Feb 10, 2021

BUY
$3.08 - $7.79 $60,676 - $153,463
19,700 New
19,700 $149,000
Q3 2020

Nov 12, 2020

SELL
$2.02 - $3.08 $37,475 - $57,140
-18,552 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$2.1 - $3.42 $78,953 - $128,581
-37,597 Reduced 66.96%
18,552 $54,000
Q1 2020

May 13, 2020

SELL
$2.31 - $4.43 $117,870 - $226,045
-51,026 Reduced 47.61%
56,149 $134,000
Q4 2019

Feb 10, 2020

BUY
$2.82 - $12.9 $172,868 - $790,782
61,301 Added 133.63%
107,175 $477,000
Q3 2019

Nov 12, 2019

SELL
$4.33 - $11.64 $161,890 - $435,196
-37,388 Reduced 44.9%
45,874 $474,000
Q2 2019

Aug 09, 2019

BUY
$4.6 - $10.13 $282,219 - $621,495
61,352 Added 280.02%
83,262 $479,000
Q1 2019

May 13, 2019

BUY
$7.19 - $32.37 $149,508 - $673,101
20,794 Added 1863.26%
21,910 $202,000
Q4 2018

Feb 06, 2019

BUY
$21.32 - $46.34 $21,661 - $47,081
1,016 Added 1016.0%
1,116 $30,000
Q3 2018

Nov 08, 2018

BUY
$36.35 - $51.7 $3,635 - $5,170
100 New
100 $5,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $29.8M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.